Morgan Stanley’s Scribe Therapeutics SCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$157K Buy
+8,536
New +$225K ﹤0.01% 6111

Other funds holding SCTX

Morgan Stanley's SCTX Position: Q3 2026 in Review

Morgan Stanley opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 8,536 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #6111 among its holdings.

63 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.

  • Morgan Stanley held 8,536 shares of Scribe Therapeutics worth $157K as of Q3 2026.
  • Scribe Therapeutics was a new Morgan Stanley position in Q3 2026.
  • Scribe Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6111 holding.
  • 63 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.